Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): Clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans

American Journal of Surgical Pathology

Volumn 34, Issue 2, 2010, Pages 190-201

  Kutzner, Heinz ^a   Mentzel, Thomas ^a   Palmedo, Gabriele ^a   Hantschke, Markus ^a   Rütten, Arno ^a   Paredes, Bruno E ^a   Schärer, Leo ^a   Guillen, Carlos Serra ^b   Requena, Luis ^c  

^a Dermatopathologie Friedrichshafen   (Germany)

^b INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

CD34; COL1A1 PDGFB fusion gene; Medallion like dermal dendrocyte hamartoma; Plaque like CD34+ dermal fibroma; Superficial (plaque like) dermatofibrosarcoma protuberans

Indexed keywords

CD34 ANTIGEN; COLIA1 PDGFB FUSION PROTEIN, HUMAN; COLIA1-PDGFB FUSION PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; DNA SEQUENCE; FEMALE; FIBROMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETICS; HAMARTOMA; HUMAN; MALE; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; CHILD; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; FEMALE; FIBROMA; GENE REARRANGEMENT; HAMARTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 75649102812     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181c7cf11     Document Type: Article

References (47)

1. Antonov J, Goldstein DR, Oberli A, et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest. 2005;85:1040-1050.
2. Bianchini L, Maire G, Guillot B, et al. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protu-berans without the COL1A1-PDGFB fusion. Virchows Arch. 2008; 452:689-696.
3. Billings SD, Folpe AL. Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy. An update. Am J Dermatopathol. 2004;26:141-155.
4. Bridge JA, Neff JR, Sandberg AA. Cytogenetic analysis of dermato-fibrosarcoma protuberans. Cancer Genet Cytogenet. 1990;49:199-202.
5. Cerio R, Spaull J, Wilson-Jones E. Histiocytoma cutis: a tumor of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol. 1989; 120:197-206.
6. Davis DA, Sanchez RL. Atrophic and plaquelike dermatofibro-sarcoma protuberans. Am J Dermatopathol. 1998;20:498-501.
7. Drury S, Anderson H, Dowsett M. Selection of reference genes for normalization of qRT-PCR data derived from FFPE breast tumors. Diagn Mol Pathol. 2009;18:103-107.
8. Drut R. Polypoid dermal dendrocyte hamartoma in a giant congenital melanocytic nevus. Int J Surg Pathol. 2007;15:73-76.
9. Farragher SM, Tanney A, Kennedy RD, et al. RNA expression analysis from formalin fixed paraffin embedded tissue. Histochem Cell Biol. 2008;130:435-445.
10. Gloster HM, Harris KR, Roenik RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35: 82-87.
11. Horenstein MG, Prieto VG, Nuckols JD, et al. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol. 2000;24:996-1003.
12. Kashima A, Yamashita A, Moriguchi K, et al. Detection of COL1A1-PDGFB fusion transcripts and platelet-derived growth factor a and b receptors in giant cell fibroblastoma of the postsacrococcygeal region. Br J Dermatol. 2006;154:983-987.
13. Koizumi H, Kumakiri M, Yamanaka K, et al. Dermal dendrocyte hamartoma with stubby white hair: a novel connective tissue hamartoma of infancy. J Am Acad Dermatol. 1995;32:318-321.
14. Lehmann U, Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods. 2001;25:409-418.
15. Llombart B, Sanmartin O, Lopez-Guerrero JA, et al. Dermatofibro-sarcoma protuberans: clinical, pathological, and genetic (COL1A 1-PDGFB) study with therapeutic implications. Histopathology. 2009;54:860-872.
16. Maire G, Fraitag S, Galmiche L, et al. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans. Arch Dermatol. 2007;143:203-210.
17. Marque M, Bessis D, Pedeutour F, et al. Medallion-like dermal dendrocyte hamartoma: the main diagnostic pitfall is congenital atrophic dermatofibrosarcoma. Br J Dermatol. 2009;160:190-193.
18. Martin L, Combemale P, Dupin M, et al. The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol. 1998;139:719-725.
19. Martin L, Piette F, Blanc P, et al. Clinical variants of the prepro-tuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol. 2005;153:932-936.
20. Martin JM, Jorda E, Monteagudo C, et al. Atrophic congenital lesion on the back. Arch Dermatol. 2006;142:921-926.
21. Massi G, LeBoit PE. Histological Diagnosis of Nevi and Melanoma. Darmstadt: Steinkopff; 2004.
22. Masuda N, Ohnishi T, Kawamoto S, et al. Analysis of chemical modification of RNA from formalin-fixed samples and optimisation of molecular biology applications for such samples. Nucleic Acids Res. 1999;27:4436-4443.
23. Mentzel T, Kutzner H. Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm. Am J Dermatopathol. 2009;31:44-49.
24. Naeem R, Lux ML, Huang S-F, et al. Ring chromosomes in dermato-fibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol. 1995;147:1553-1558.
25. Ohata C, Kawahara K. CD34-reactive myxoid dermal dendrocyto-ma. Am J Dermatopathol. 2002;24:50-53.
26. Paik S, Kim C, Song Y, et al. Technology insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol. 2005;2:246-254.
27. Patel KU, Szabo SS, Hernandez VS, et al. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol. 2008;39: 184-193.
28. Pedeutour F, Coindre JM, Sozzi G, et al. Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cyto-genet. 1994;76:1-9.
29. Pedeutour F, Simon MP, Minoletti F, et al. Translocation, t(17;22) (q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet. 1996; 72:171-174.
30. Penland SK, Keku TO, Torrice C, et al. RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest. 2007;87: 383-391.
31. + dermal proliferation. Am J Dermatopathol. 2002;24:85-88.
32. Price VE, Fletcher JA, Zielenska M, et al. Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans. Pediatr Blood Cancer. 2005;44:511-515.
33. Ratner D, Thomas CO, Johnson TM, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol. 1997;37:600-613.
34. Rodriguez-Jurado R, Palacios C, Duran-McKinster C, et al. Medallion-like dermal dendrocyte hamartoma: a new clinically and histopathologically distinct lesion. J Am Acad Dermatol. 2004; 51:359-363.
35. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet. 2003;140:1-12.
36. Shah KN, Anderson E, Junkins-Hopkins J, et al. Medallion-like dermal dendrocyte hamartoma. Pediatr Dermatol. 2007;24:632-636.
37. Silverman JS, Brustein S. Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages. J Cutan Pathol. 1996;23:551-557.
38. Simon MP, Navarro M, Roux D, et al. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuber-ans. Oncogene. 2001;20:2965-2975.
39. Singh S, Kaye S, Francis ND, et al. Revisiting the past: utilizing archival tissue for the detection and quantification of gene expression. Br J Dermatol. 2009;160:885-886.
40. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibro-sarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 2003; 37:1-19.
41. Szollosi Z, Scholtz B, Egervari K, et al. Transformed dermatofi-brosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas. J Clin Pathol. 2007;60:190-194.
42. Takahira T, Oda Y, Tamiya S, et al. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod Pathol. 2007;20:668-675.
43. Tardio JC. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions. J Cutan Pathol. 2009;36:89-102.
44. Terrier-Lacombe MJ, Guillou L, Maire G, et al. Dermatofibrosar-coma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data-a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2003;27:27-39.
45. Wang J, Hisaoka M, Shimajiri S, et al. Detection of the COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol. 1999;8: 113-119.
46. Wang J, Morimitsu Y, Okamoto S, et al. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans. J Mol Diagn. 2000;2:47-52.
47. Westerhof W, Konrad K. Blue-red papules and pseudoatrophic macules: additional cutaneous signs in neurofibromatosis. Arch Dermatol. 1982;118:577-581.